Probing conformational plasticity of the activation domain of trypsin: the role of glycine hinges.

Trypsin-like serine proteases play essential roles in diverse physiological processes such as hemostasis, apoptosis, signal transduction, reproduction, immune response, matrix remodeling, development, and differentiation. All of these proteases share an intriguing activation mechanism that involves the transition of an unfolded domain (activation domain) of the zymogen to a folded one in the active enzyme. During this conformational change, activation domain segments move around highly conserved glycine hinges. In the present study, hinge glycines were replaced by alanine residues via site directed mutagenesis. The effects of these mutations on the interconversion of the zymogen-like and active conformations as well as on catalytic activity were studied. Mutant trypsins showed zymogen-like structures to varying extents characterized by increased flexibility of some activation domain segments, a more accessible N-terminus and a deformed substrate binding site. Our results suggest that the trypsinogen to trypsin transition is hindered by the mutations, which results in a shift of the equilibrium between the inactive zymogen-like and active enzyme conformations toward the inactive state. Our data also showed, however, that the inactive conformations of the various mutants differ from each other. Binding of substrate analogues shifted the conformational equilibrium toward the active enzyme since inhibited forms of the trypsin mutants showed similar structural features as the wild-type enzyme. The catalytic activity of the mutants correlated with the proper conformation of the active site, which could be supported by varying conformations of the N-terminus and the autolysis loop. Transient kinetic measurements confirmed the existence of an inactive to active conformational transition occurring prior to substrate binding.

[1]  L. Gráf,et al.  Site directed mutagenesis at position 193 of human trypsin 4 alters the rate of conformational change during activation: Role of local internal viscosity in protein dynamics , 2007, Proteins.

[2]  W. Sandoval,et al.  Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist , 2007, Proceedings of the National Academy of Sciences.

[3]  L. Gráf,et al.  Thermodynamic Analysis Reveals Structural Rearrangement during the Acylation Step in Human Trypsin 4 on 4-Methylumbelliferyl 4-Guanidinobenzoate Substrate Analogue* , 2006, Journal of Biological Chemistry.

[4]  A. Kaur,et al.  Interchromosomal segmental duplications explain the unusual structure of PRSS3, the gene for an inhibitor-resistant trypsinogen. , 2005, Molecular biology and evolution.

[5]  P. Krüger,et al.  Simulation of the activation of α‐chymotrypsin: Analysis of the pathway and role of the propeptide , 2004, Protein science : a publication of the Protein Society.

[6]  A. Hengge,et al.  Role of protein conformational mobility in enzyme catalysis: acylation of alpha-chymotrypsin by specific peptide substrates. , 2004, Biochemistry.

[7]  Manuel C. Peitsch,et al.  SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..

[8]  R. Stein,et al.  Mechanistic origins of the substrate selectivity of serine proteases. , 2003, Biochemistry.

[9]  L. Hedstrom Serine protease mechanism and specificity. , 2002, Chemical reviews.

[10]  R. Camire Prothrombinase Assembly and S1 Site Occupation Restore the Catalytic Activity of FXa Impaired by Mutation at the Sodium-binding Site* , 2002, The Journal of Biological Chemistry.

[11]  D. Perry,et al.  Factor X deficiency. , 2002, Blood reviews.

[12]  J. Hajdu,et al.  Crystal structure reveals basis for the inhibitor resistance of human brain trypsin. , 2002, Journal of molecular biology.

[13]  L Szilágyi,et al.  Comparative in Vitro Studies on Native and Recombinant Human Cationic Trypsins , 2001, The Journal of Biological Chemistry.

[14]  C. Jeffery,et al.  The energetic cost of induced fit catalysis: Crystal structures of trypsinogen mutants with enhanced activity and inhibitor affinity , 2001, Protein science : a publication of the Protein Society.

[15]  K. Wulff,et al.  Twenty two novel mutations of the factor VII gene in factor VII deficiency , 2000, Human mutation.

[16]  R. Maroun,et al.  The Contribution of Residues 192 and 193 to the Specificity of Snake Venom Serine Proteinases* , 2000, The Journal of Biological Chemistry.

[17]  D. Ringe,et al.  Comparison of anionic and cationic trypsinogens: The anionic activation domain is more flexible in solution and differs in its mode of BPTI binding in the crystal structure , 2008, Protein science : a publication of the Protein Society.

[18]  T. Lin,et al.  Activating a zymogen without proteolytic processing: mutation of Lys15 and Asn194 activates trypsinogen. , 1998, Biochemistry.

[19]  A. R. Khan,et al.  Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes , 1998, Protein science : a publication of the Protein Society.

[20]  Elena Conti,et al.  X‐ray and spectrophotometric studies of the binding of proflavin to the S1 specificity pocket of human α‐thrombin , 1998 .

[21]  S. Hubbard,et al.  The structural aspects of limited proteolysis of native proteins. , 1998, Biochimica et biophysica acta.

[22]  P. Brick,et al.  X-ray and spectrophotometric studies of the binding of proflavin to the S1 specificity pocket of human alpha-thrombin. , 1998, FEBS letters.

[23]  Neil D. Rawlings,et al.  Handbook of proteolytic enzymes , 1998 .

[24]  Y. Engelborghs,et al.  Modelling pathways of alpha-chymotrypsin activation and deactivation. , 1997, Protein engineering.

[25]  M. Kito,et al.  Identification and Expression of the cDNA-encoding Human Mesotrypsin(ogen), an Isoform of Trypsin with Inhibitor Resistance* , 1997, The Journal of Biological Chemistry.

[26]  M. Goossens,et al.  Haemophilia B: database of point mutations and short additions and deletions, 7th edition , 1990, Nucleic Acids Res..

[27]  T. Lin,et al.  Hydrophobic interactions control zymogen activation in the trypsin family of serine proteases. , 1996, Biochemistry.

[28]  M. Pinotti,et al.  Mutation pattern in clinically asymptomatic coagulation factor VII deficiency , 1996, Human mutation.

[29]  L. Gráf Structural Basis of Serine Protease Action: The Fourth Dimension , 1995 .

[30]  P. Reitsma,et al.  Haemophilia B: database of point mutations and short additions and deletions, fifth edition, 1994. , 1994, Nucleic acids research.

[31]  B. Müller-Hill,et al.  Cloning of the cDNA encoding human brain trypsinogen and characterization of its product. , 1993, Gene.

[32]  Pedro Mendes,et al.  GEPASI: a software package for modelling the dynamics, steady states and control of biochemical and other systems , 1993, Comput. Appl. Biosci..

[33]  B. Müller-Hill,et al.  Identification of cDNAs encoding two novel rat pancreatic serine proteases. , 1992, Gene.

[34]  C. Tellier,et al.  Diastereotopic covalent binding of the natural inhibitor leupeptin to trypsin: detection of two interconverting hemiacetals by solution and solid-state NMR spectroscopy. , 1991, Biochemistry.

[35]  P. Reitsma,et al.  Haemophilia B: database of point mutations and short additions and deletions. , 1990, Nucleic acids research.

[36]  M. Karplus,et al.  Trypsinogen-trypsin transition: a molecular dynamics study of induced conformational change in the activation domain. , 1987, Biochemistry.

[37]  W. Rutter,et al.  Redesigning trypsin: alteration of substrate specificity. , 1985, Science.

[38]  H. Neurath,et al.  Evolution of proteolytic enzymes. , 1984, Science.

[39]  R. Huber,et al.  Functional significance of flexibility in proteins , 1982, Biopolymers.

[40]  Robert Huber,et al.  On the disordered activation domain in trypsinogen: chemical labelling and low‐temperature crystallography , 1982 .

[41]  R. Huber,et al.  Structural basis of the activation and action of trypsin , 1978 .

[42]  R. Huber,et al.  The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. The refined crystal structures of the bovine trypsinogen-pancreatic trypsin inhibitor complex and of its ternary complex with Ile-Val at 1.9 A resolution. , 1978, Journal of molecular biology.

[43]  R. Huber,et al.  Crystal structure of bovine trypsinogen at 1-8 A resolution. II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin. , 1977, Journal of molecular biology.

[44]  W. Bode,et al.  The refined crystal structure of bovine beta-trypsin at 1.8 A resolution. II. Crystallographic refinement, calcium binding site, benzamidine binding site and active site at pH 7.0. , 1975, Journal of molecular biology.

[45]  H. Neurath,et al.  The phylogeny of trypsin-related serine proteases and their zymogens. New methods for the investigation of distant evolutionary relationships. , 1975, Journal of molecular biology.

[46]  A. Fersht,et al.  Conformational equilibria in -and -chymotrypsin. The energetics and importance of the salt bridge. , 1972, Journal of molecular biology.

[47]  A. Fersht Conformational equilibria and the salt bridge in chymotrypsin. , 1972, Cold Spring Harbor symposia on quantitative biology.

[48]  A. Fersht,et al.  Equilibrium and rate constants for the interconversion of two conformations of -chymotrypsin. The existence of a catalytically inactive conformation at neutral p H. , 1971, Journal of molecular biology.

[49]  W. Spomer,et al.  The hydrolysis of alpha-N-benzoyl-L-argininamide catalyzed by trypsin and acetyltrypsin. Dependence on pH. , 1971, Biochimica et biophysica acta.

[50]  S. Moore,et al.  Activity of bovine pancreatic deoxyribonuclease A with modified amino groups. , 1971, The Journal of biological chemistry.

[51]  S. Bernhard,et al.  The optical detection of transients in trypsin- and chymotrypsin-catalyzed reactions. , 1965, Proceedings of the National Academy of Sciences of the United States of America.

[52]  G. Stark,et al.  Reactions of the Cyanate Present in Aqueous Urea with Amino Acids and Proteins , 1960 .